InvestorsHub Logo
Followers 18
Posts 1424
Boards Moderated 0
Alias Born 11/01/2018

Re: RedShoulder post# 327167

Tuesday, 08/24/2021 3:01:51 PM

Tuesday, August 24, 2021 3:01:51 PM

Post# of 458401
RS you posted.

In fact the data for PDD and PD was highly successful with p values backing up the win.

Strangely the success of the PDD/PD trial has been completely discounted in the SP, which is not logical since that data shows Anavex will own the SOC of that multi-Billion market. Mayo showed in his analysis of the current SOC to be inferior to A2-73 in effectiveness and without the bad side effects of the current SOC.

Yes. This data should have taken AVXL MC to $7 to $9 billion. New SOC drug.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News